According to Pacific Biosciences 's latest financial reports the company's current earnings (TTM) are -$0.32 B. In 2022 the company made an earning of -$0.32 B a decrease over its 2021 earnings that were of -$0.28 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.32 B | 1.24% |
2022 | -$0.32 B | 14.33% |
2021 | -$0.28 B | -1034.84% |
2020 | $29.4 M | -134.95% |
2019 | -$84.14 M | -17.97% |
2018 | -$0.11 B | 11.25% |
2017 | -$92.19 M | 23.95% |
2016 | -$74.38 M | 134.65% |
2015 | -$31.7 M | -52.09% |
2014 | -$66.16 M | -16.56% |
2013 | -$79.3 M | -16.08% |
2012 | -$94.49 M | -13.78% |
2011 | -$0.11 B | -21.76% |
2010 | -$0.15 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $6.29 B | -2,079.51% | ๐บ๐ธ USA |
General Electric GE | $11.30 B | -3,654.51% | ๐บ๐ธ USA |
Illumina ILMN | -$1.04 B | 226.88% | ๐บ๐ธ USA |
PerkinElmer
PKI | $0.47 B | -249.14% | ๐บ๐ธ USA |
Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |
NanoString Technologies NSTG | -$0.16 B | -50.14% | ๐บ๐ธ USA |